首页 > 最新文献

ADMET and DMPK最新文献

英文 中文
Nanomaterials as catalysts for the sensitive and selective determination of diclofenac 纳米材料作为催化剂灵敏、选择性地测定双氯芬酸
IF 2.5 Q2 CHEMISTRY, MEDICINAL Pub Date : 2023-11-16 DOI: 10.5599/admet.2116
T. Dodevska, I. Shterev
Background  and  purpose: Diclofenac (DCF) is a non-steroidal anti-inflammatory drug possessing analgesic and antipyretic properties. It is used for the treatment of rheumatoid arthritis pain, osteoarthritis, and acute muscle pain conditions and can be administrated orally, topically or intravenously. Because of its widespread use, hydrophilicity, stability and poor degradation (bioaccumulation in the food chain), DCF is an emerging chemical contaminant that can cause adverse effects in the ecosystems. Taking into account the consumption of DCF in pharmaceutical formulations and its negative impact on the environment, the development of new sensitive, selective, cheap, fast, and online capable analytical devices is needed for on-site applications. Experimental  approach: This brief review attempts to cover the recent developments related to the use of nanomaterials as catalysts for electrochemical determination of DCF in pharmaceutical formulations, biological fluids and environmental samples. Key results: The article aims to prove how electrochemical sensors represent reliable alternatives to conventional methods for DCF analysis. Conclusion: The manuscript highlights the progress in the development of electrochemical sensors for DCF detection. We have analyzed numerous recent papers (mainly since 2019) on sensors developed for the quantitative determination of DCF, indicating the limit of detection, linear range, stability, reproducibility, and analytical applications. Current challenges related to the sensor design and future perspectives are outlined.
背景和目的:双氯芬酸(Diclofenac,DCF)是一种非甾体抗炎药,具有镇痛和解热作用。它可用于治疗类风湿性关节炎疼痛、骨关节炎和急性肌肉疼痛,可口服、局部用药或静脉注射。由于其使用广泛、亲水性、稳定性和降解性差(在食物链中的生物累积性),DCF 是一种新出现的化学污染物,可对生态系统造成不利影响。考虑到 DCF 在药物制剂中的消耗量及其对环境的负面影响,需要开发新的灵敏度高、选择性强、廉价、快速且可在线分析的装置,以满足现场应用的需要。实验方法:本简要综述试图介绍使用纳米材料作为催化剂对药物制剂、生物液体和环境样品中的 DCF 进行电化学测定的最新进展。主要成果:文章旨在证明电化学传感器如何成为 DCF 分析传统方法的可靠替代方法。结论:该手稿重点介绍了用于 DCF 检测的电化学传感器的开发进展。我们分析了近期(主要是 2019 年以来)有关开发用于定量测定 DCF 的传感器的大量论文,指出了传感器的检测极限、线性范围、稳定性、重现性和分析应用。概述了当前与传感器设计相关的挑战和未来展望。
{"title":"Nanomaterials as catalysts for the sensitive and selective determination of diclofenac","authors":"T. Dodevska, I. Shterev","doi":"10.5599/admet.2116","DOIUrl":"https://doi.org/10.5599/admet.2116","url":null,"abstract":"Background  and  purpose: Diclofenac (DCF) is a non-steroidal anti-inflammatory drug possessing analgesic and antipyretic properties. It is used for the treatment of rheumatoid arthritis pain, osteoarthritis, and acute muscle pain conditions and can be administrated orally, topically or intravenously. Because of its widespread use, hydrophilicity, stability and poor degradation (bioaccumulation in the food chain), DCF is an emerging chemical contaminant that can cause adverse effects in the ecosystems. Taking into account the consumption of DCF in pharmaceutical formulations and its negative impact on the environment, the development of new sensitive, selective, cheap, fast, and online capable analytical devices is needed for on-site applications. Experimental  approach: This brief review attempts to cover the recent developments related to the use of nanomaterials as catalysts for electrochemical determination of DCF in pharmaceutical formulations, biological fluids and environmental samples. Key results: The article aims to prove how electrochemical sensors represent reliable alternatives to conventional methods for DCF analysis. Conclusion: The manuscript highlights the progress in the development of electrochemical sensors for DCF detection. We have analyzed numerous recent papers (mainly since 2019) on sensors developed for the quantitative determination of DCF, indicating the limit of detection, linear range, stability, reproducibility, and analytical applications. Current challenges related to the sensor design and future perspectives are outlined.","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"34 12","pages":""},"PeriodicalIF":2.5,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139266767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral bioavailability enhancement of doxazosin mesylate: Nanosuspension versus self-nanoemulsifying drug delivery systems 甲磺酸多沙唑嗪的口服生物利用度增强:纳米悬浮液与自纳米乳化给药系统
Q2 CHEMISTRY, MEDICINAL Pub Date : 2023-11-03 DOI: 10.5599/admet.2022
Al Zahraa G. Al Ashmawy, Mohammad H. Alyami, Noura G. Eissa, Gehan F. Balata, Hanan M. El Nahas
Background and purpose: Doxazosin mesylate (DOX) is an antihypertensive drug that possesses poor water solubility and, hence, poor release properties. Both nanosuspensions and self-nanoemulsifying drug delivery systems (SNEDDS) are becoming nanotechnology techniques for the enhancement of water solubility of different drugs. Experimental approach: The study's goal was to identify the best drug delivery system able to enhance the release and antihypertensive effect of DOX by comparing the physical characteristics such as particle size, zeta potential, entrapment efficiency, release rate, and main arterial blood pressure of DOX-loaded nanosuspensions and SNEDDS in liquid and solid form. Key results: DOX nanosuspension preparation had a particle size of 385±13 nm, poly-dispersity index of 0.049±3, zeta potential of 50 ± 4 mV and drug release after 20 min (91±0.43 %). Liquid SNEDDS had a droplet size of 224±15 nm, poly-dispersity index of (0.470±0.01), zeta potential of -5±0.10 mV and DR20min of 93±4 %. Solid SEDDS showed particle size of 79±14 nm, poly-dispersity index of 1±0.00, a zeta potential of -18 ±0.26 mv and DR20min of 100 ±2.72 %. Conclusion: Finally, in terms of the mean arterial blood pressure lowering, solid SNEDDS performed better effect than both liquid SNEDDS and nanosuspension (P >0.05).
背景和目的:甲磺酸多沙唑嗪(DOX)是一种抗高血压药物,水溶性差,因此释放性差。纳米悬浮液和自纳米乳化给药系统(SNEDDS)正在成为提高不同药物水溶性的纳米技术。实验方法:本研究的目的是通过比较DOX纳米混悬液和SNEDDS在液体和固体形态下的粒径、zeta电位、包裹效率、释放速率和主动脉血压等物理特性,确定能够增强DOX释放和降压效果的最佳给药系统。关键结果:DOX纳米混悬剂的粒径为385±13 nm,多分散指数为0.049±3,zeta电位为50±4 mV, 20 min后药物释放率为91±0.43%。SNEDDS液滴尺寸为224±15 nm,多分散性指数为(0.470±0.01),zeta电位为-5±0.10 mV, DR20min为93±4%。固体SEDDS的粒径为79±14 nm,多分散性指数为1±0.00,zeta电位为-18±0.26 mv, DR20min为100±2.72%。结论:最后,在降低平均动脉血压方面,固体SNEDDS的效果优于液体SNEDDS和纳米混悬液(P >0.05)。
{"title":"Oral bioavailability enhancement of doxazosin mesylate: Nanosuspension versus self-nanoemulsifying drug delivery systems","authors":"Al Zahraa G. Al Ashmawy, Mohammad H. Alyami, Noura G. Eissa, Gehan F. Balata, Hanan M. El Nahas","doi":"10.5599/admet.2022","DOIUrl":"https://doi.org/10.5599/admet.2022","url":null,"abstract":"Background and purpose: Doxazosin mesylate (DOX) is an antihypertensive drug that possesses poor water solubility and, hence, poor release properties. Both nanosuspensions and self-nanoemulsifying drug delivery systems (SNEDDS) are becoming nanotechnology techniques for the enhancement of water solubility of different drugs. Experimental approach: The study's goal was to identify the best drug delivery system able to enhance the release and antihypertensive effect of DOX by comparing the physical characteristics such as particle size, zeta potential, entrapment efficiency, release rate, and main arterial blood pressure of DOX-loaded nanosuspensions and SNEDDS in liquid and solid form. Key results: DOX nanosuspension preparation had a particle size of 385±13 nm, poly-dispersity index of 0.049±3, zeta potential of 50 ± 4 mV and drug release after 20 min (91±0.43 %). Liquid SNEDDS had a droplet size of 224±15 nm, poly-dispersity index of (0.470±0.01), zeta potential of -5±0.10 mV and DR20min of 93±4 %. Solid SEDDS showed particle size of 79±14 nm, poly-dispersity index of 1±0.00, a zeta potential of -18 ±0.26 mv and DR20min of 100 ±2.72 %. Conclusion: Finally, in terms of the mean arterial blood pressure lowering, solid SNEDDS performed better effect than both liquid SNEDDS and nanosuspension (P >0.05).","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"8 3","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135872934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Special issue devoted to the IAPC-10 Meeting: Joint World Conferences on Physico-Chemical Methods in Drug Discovery and Development and on ADMET and DMPK. IAPC-10 会议特刊:药物发现和开发中的物理化学方法世界联席会议》和《ADMET 和 DMPK》。
IF 3.4 Q2 CHEMISTRY, MEDICINAL Pub Date : 2023-10-31 eCollection Date: 2024-01-01 DOI: 10.5599/admet.2541
Tatjana Verbić, Zoran Mandić
{"title":"Special issue devoted to the IAPC-10 Meeting: Joint World Conferences on Physico-Chemical Methods in Drug Discovery and Development and on ADMET and DMPK.","authors":"Tatjana Verbić, Zoran Mandić","doi":"10.5599/admet.2541","DOIUrl":"https://doi.org/10.5599/admet.2541","url":null,"abstract":"","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"12 5","pages":"703-704"},"PeriodicalIF":3.4,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11542718/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142612119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: A comprehensive review 纳米材料作为克服血脑屏障的药物递送剂:综述
Q2 CHEMISTRY, MEDICINAL Pub Date : 2023-10-31 DOI: 10.5599/admet.2043
Mangesh Kulkarni, Krishi Patel, Ayush Patel, Swayamprakash Patel, Jagruti Desai, Mehul Patel, Umang Shah, Ashish Patel, Nilay Solanki
Background and Purpose: The blood-brain barrier (BBB), a critical interface of specialized endothelial cells, plays a pivotal role in regulating molecular and ion transport between the central nervous system (CNS) and systemic circulation. Experimental Approach: This review aims to delve into the intricate architecture and functions of the BBB while addressing challenges associated with delivering therapeutics to the brain. Historical milestones and contemporary insights underscore the BBB's significance in protecting the CNS. Key Results: Innovative approaches for enhanced drug transport include intranasal delivery exploiting olfactory and trigeminal pathways, as well as techniques like temporary BBB opening through chemicals, receptors, or focused ultrasound. These avenues hold the potential to reshape conventional drug delivery paradigms and address the limitations posed by the BBB's selectivity. Conclusion: This review underscores the vital role of the BBB in maintaining CNS health and emphasizes the importance of effective drug delivery through this barrier. Nanoparticles emerge as promising candidates to overcome BBB limitations and potentially revolutionize the treatment of CNS disorders. As research progresses, the application of nanomaterials shows immense potential for advancing neurological therapeutics, albeit with careful consideration of safety aspects.
背景与目的:血脑屏障(BBB)是特化内皮细胞的重要界面,在调节中枢神经系统(CNS)和体循环之间的分子和离子运输中起着关键作用。实验方法:本综述旨在深入研究血脑屏障的复杂结构和功能,同时解决与向大脑提供治疗相关的挑战。历史的里程碑和当代的见解强调了BBB在保护中枢神经系统方面的重要性。关键结果:增强药物运输的创新方法包括利用嗅觉和三叉神经通路的鼻内给药,以及通过化学物质、受体或聚焦超声临时打开血脑屏障等技术。这些途径有可能重塑传统的给药模式,并解决血脑屏障选择性所带来的限制。结论:本综述强调了血脑屏障在维持中枢神经系统健康中的重要作用,并强调了通过这一屏障有效给药的重要性。纳米颗粒有望克服血脑屏障的局限性,并可能彻底改变中枢神经系统疾病的治疗。随着研究的进展,纳米材料的应用在推进神经治疗方面显示出巨大的潜力,尽管需要仔细考虑安全性方面。
{"title":"Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: A comprehensive review","authors":"Mangesh Kulkarni, Krishi Patel, Ayush Patel, Swayamprakash Patel, Jagruti Desai, Mehul Patel, Umang Shah, Ashish Patel, Nilay Solanki","doi":"10.5599/admet.2043","DOIUrl":"https://doi.org/10.5599/admet.2043","url":null,"abstract":"Background and Purpose: The blood-brain barrier (BBB), a critical interface of specialized endothelial cells, plays a pivotal role in regulating molecular and ion transport between the central nervous system (CNS) and systemic circulation. Experimental Approach: This review aims to delve into the intricate architecture and functions of the BBB while addressing challenges associated with delivering therapeutics to the brain. Historical milestones and contemporary insights underscore the BBB's significance in protecting the CNS. Key Results: Innovative approaches for enhanced drug transport include intranasal delivery exploiting olfactory and trigeminal pathways, as well as techniques like temporary BBB opening through chemicals, receptors, or focused ultrasound. These avenues hold the potential to reshape conventional drug delivery paradigms and address the limitations posed by the BBB's selectivity. Conclusion: This review underscores the vital role of the BBB in maintaining CNS health and emphasizes the importance of effective drug delivery through this barrier. Nanoparticles emerge as promising candidates to overcome BBB limitations and potentially revolutionize the treatment of CNS disorders. As research progresses, the application of nanomaterials shows immense potential for advancing neurological therapeutics, albeit with careful consideration of safety aspects.","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135809267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advances in nanomaterial-based drug delivery systems for melanoma therapy 基于纳米材料的黑色素瘤药物递送系统的最新进展
Q2 CHEMISTRY, MEDICINAL Pub Date : 2023-10-24 DOI: 10.5599/admet.2088
Rabinarayan Parhi, Partha Pratim Kaishap, Goutam Kumar Jena
Background and Purpose: Safe and effective drug delivery is crucial for the treatment of cancer, which is quite impossible to achieve through traditional methods. Among all types of cancer, skin melanoma is known for its aggressive metastasizing ability and an unprecedented higher degree of lethalness, limiting the overall therapeutic efficacy. Here, we focus on the different types of nanomaterials (NMs) and their drug delivery applications against melanoma. Experimental Approach: All relevant publications, including research papers, reviews, chapters and patents, were assessed using search engines such as Scopus and PubMed, up to the end of August of 2023. The keywords used in the search were: nanomaterials, melanoma, drug delivery routes for melanoma, and nanomaterial-based drug delivery systems (DDS). Most of the publications out of 234 cited in this review are from the last five years. Key Results: The recent advancement and mechanism of action of various NMs against melanoma, including inorganic metallic and carbon-based NMs, organic polymeric and lipid-based NMs, and cell-derived vesicles are discussed. We also focus on the application of different NMs in the delivery of therapeutic agents for melanoma therapy. In addition, the skin and melanoma, genetic mutation and pathways for melanoma, conventional treatment options, and delivery routes for therapeutic agents are also discussed briefly. Conclusion: There are few NM-based DDS developed in the lab set up recently. The findings of this review will pave the path for the development of NM-based DDS on an industrial scale and help in the better management of skin melanoma.
背景与目的:安全有效的给药对于癌症的治疗至关重要,这是传统方法无法实现的。在所有类型的癌症中,皮肤黑色素瘤以其侵袭性转移能力和前所未有的高致死率而闻名,限制了整体治疗效果。在这里,我们专注于不同类型的纳米材料(NMs)及其对黑色素瘤的药物递送应用。实验方法:截至2023年8月底,使用Scopus和PubMed等搜索引擎对所有相关出版物(包括研究论文、综述、章节和专利)进行评估。搜索中使用的关键词是:纳米材料、黑色素瘤、黑色素瘤的药物传递途径和基于纳米材料的药物传递系统(DDS)。在这篇综述中引用的234篇论文中,大多数都是最近5年发表的。综述了无机金属基、碳基NMs、有机聚合物基、脂质NMs、细胞源性囊泡等多种NMs抗黑色素瘤的最新进展及其作用机制。我们还关注不同NMs在黑色素瘤治疗药物输送中的应用。此外,皮肤和黑色素瘤,基因突变和黑色素瘤的途径,传统的治疗方案,以及药物的递送途径也进行了简要的讨论。结论:近年来建立的实验室研制的纳米基DDS较少。本综述的研究结果将为基于纳米颗粒的DDS的工业化发展铺平道路,并有助于更好地治疗皮肤黑色素瘤。
{"title":"Recent advances in nanomaterial-based drug delivery systems for melanoma therapy","authors":"Rabinarayan Parhi, Partha Pratim Kaishap, Goutam Kumar Jena","doi":"10.5599/admet.2088","DOIUrl":"https://doi.org/10.5599/admet.2088","url":null,"abstract":"Background and Purpose: Safe and effective drug delivery is crucial for the treatment of cancer, which is quite impossible to achieve through traditional methods. Among all types of cancer, skin melanoma is known for its aggressive metastasizing ability and an unprecedented higher degree of lethalness, limiting the overall therapeutic efficacy. Here, we focus on the different types of nanomaterials (NMs) and their drug delivery applications against melanoma. Experimental Approach: All relevant publications, including research papers, reviews, chapters and patents, were assessed using search engines such as Scopus and PubMed, up to the end of August of 2023. The keywords used in the search were: nanomaterials, melanoma, drug delivery routes for melanoma, and nanomaterial-based drug delivery systems (DDS). Most of the publications out of 234 cited in this review are from the last five years. Key Results: The recent advancement and mechanism of action of various NMs against melanoma, including inorganic metallic and carbon-based NMs, organic polymeric and lipid-based NMs, and cell-derived vesicles are discussed. We also focus on the application of different NMs in the delivery of therapeutic agents for melanoma therapy. In addition, the skin and melanoma, genetic mutation and pathways for melanoma, conventional treatment options, and delivery routes for therapeutic agents are also discussed briefly. Conclusion: There are few NM-based DDS developed in the lab set up recently. The findings of this review will pave the path for the development of NM-based DDS on an industrial scale and help in the better management of skin melanoma.","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"32 7","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135266651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nanomaterials in biomedicine, drug delivery and pharmaceutical analysis. 生物医学、药物输送和药物分析中的纳米材料。
IF 2.5 Q2 CHEMISTRY, MEDICINAL Pub Date : 2023-10-16 eCollection Date: 2023-01-01 DOI: 10.5599/admet.2125
Hassan Karimi-Maleh, Afsaneh L Sanati, Rozhin Darabi
After the introduction of nanotechnology as a new science, there were tremendous changes in its application. Nanomaterials rapidly penetrate a diverse area of biomedicine and pharmaceutical research, including drug development, drug delivery, tissue engineering and medicinal chemistry. Its versatile use helps in alleviating complex difficulties faced with drug administration and absorption, controlled release, targeted delivery and cellular uptake. Due to their distinctive physico-chemical properties and ability to form various solid-state formulations, they find increased use in the preparation of new drug formulations, imaging techniques and particularly in medicinal chemistry as catalysts for the sensitive determination of drugs and other biologically active compounds. The role of nanomaterials as catalysts in the preparation of substances with pharmacological properties, the preparation of sensors, or the degradation and removal of medicinal compounds polluting the environment is undeniable.
{"title":"Nanomaterials in biomedicine, drug delivery and pharmaceutical analysis.","authors":"Hassan Karimi-Maleh, Afsaneh L Sanati, Rozhin Darabi","doi":"10.5599/admet.2125","DOIUrl":"https://doi.org/10.5599/admet.2125","url":null,"abstract":"After the introduction of nanotechnology as a new science, there were tremendous changes in its application. Nanomaterials rapidly penetrate a diverse area of biomedicine and pharmaceutical research, including drug development, drug delivery, tissue engineering and medicinal chemistry. Its versatile use helps in alleviating complex difficulties faced with drug administration and absorption, controlled release, targeted delivery and cellular uptake. Due to their distinctive physico-chemical properties and ability to form various solid-state formulations, they find increased use in the preparation of new drug formulations, imaging techniques and particularly in medicinal chemistry as catalysts for the sensitive determination of drugs and other biologically active compounds. The role of nanomaterials as catalysts in the preparation of substances with pharmacological properties, the preparation of sensors, or the degradation and removal of medicinal compounds polluting the environment is undeniable.","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"11 4","pages":"433-434"},"PeriodicalIF":2.5,"publicationDate":"2023-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626511/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71476979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of olanzapine solid dispersion by spray drying technique using screening design for solubility enhancement. 采用提高溶解度的筛选设计,通过喷雾干燥技术开发奥氮平固体分散体。
IF 2.5 Q2 CHEMISTRY, MEDICINAL Pub Date : 2023-10-06 eCollection Date: 2023-01-01 DOI: 10.5599/admet.1998
Leena Patil, Umakant Verma, Rahul Rajput, Pritam Patil, Aniruddha Chaterjee, Jitendra Naik

Introduction: Olanzapine (OLZ) is a psychotropic class drug commonly used to treat schizophrenia, bipolar disorder, and acute manic episodes. It has less water solubility, resulting in a slow dissolution rate and oral bioavailability. Therefore, the development in oral dosage forms is required to enhance the drug solubility.

Method: The solid dispersion of olanzapine is prepared by spray drying technique. The solution of polyvinylpyrrolidone K-30 (PVP K-30), mono amino glycyrrhizinate pentahydrate (GLY), OLZ and silicon dioxide were dissolved in distilled water and ethanol and spray dried to get the solid dispersion. Solid dispersion was characterized for surface morphology, solubility, encapsulation efficiency (EE), X-ray diffraction (X-RD), Differential Scanning Calorimeter (DSC) and drug-polymer interaction by Fourier transforms infrared spectroscopy.

Results: The amorphous nature of the drug's incorporation in solid dispersion was confirmed by X-RD analysis. Prepared solid dispersion showed higher solubility, 11.51 mg, than pure OLZ (0.983 mg ml-1), while the range of EE was found to be between 64 to 90 %.

Conclusions: The solubility and dissolution rate of the OLZ can effectively increase by spray-dried solid dispersion. Plackett-Burman screening design plays a vital role in understanding the effect of independent variables on EE and solubility.

简介:奥氮平(OLZ)是一种精神类药物,常用于治疗精神分裂症、双相情感障碍和急性躁狂发作。它的水溶性较低,导致溶解速度慢,口服生物利用度低。因此,需要开发口服剂型以提高药物溶解度。方法:采用喷雾干燥法制备奥氮平固体分散体。将聚乙烯吡咯烷酮K-30(PVP K-30)、单氨基甘草酸盐五水合物(GLY)、OLZ和二氧化硅的溶液溶解在蒸馏水和乙醇中,并喷雾干燥以获得固体分散体。通过傅立叶变换红外光谱对固体分散体的表面形态、溶解度、包封效率(EE)、X射线衍射(X-RD)、差示扫描量热仪(DSC)和药物-聚合物相互作用进行了表征。结果:X-RD分析证实了药物在固体分散体中的掺入是无定形的。所制备的固体分散体的溶解度为11.51mg,高于纯OLZ(0.983mg/ml-1),而EE的范围在64%至90%之间。结论:喷雾干燥固体分散体可以有效提高OLZ的溶解度和溶解速率。Plackett-Burman筛选设计在理解自变量对EE和溶解度的影响方面发挥着至关重要的作用。
{"title":"Development of olanzapine solid dispersion by spray drying technique using screening design for solubility enhancement.","authors":"Leena Patil, Umakant Verma, Rahul Rajput, Pritam Patil, Aniruddha Chaterjee, Jitendra Naik","doi":"10.5599/admet.1998","DOIUrl":"10.5599/admet.1998","url":null,"abstract":"<p><strong>Introduction: </strong>Olanzapine (OLZ) is a psychotropic class drug commonly used to treat schizophrenia, bipolar disorder, and acute manic episodes. It has less water solubility, resulting in a slow dissolution rate and oral bioavailability. Therefore, the development in oral dosage forms is required to enhance the drug solubility.</p><p><strong>Method: </strong>The solid dispersion of olanzapine is prepared by spray drying technique. The solution of polyvinylpyrrolidone K-30 (PVP K-30), mono amino glycyrrhizinate pentahydrate (GLY), OLZ and silicon dioxide were dissolved in distilled water and ethanol and spray dried to get the solid dispersion. Solid dispersion was characterized for surface morphology, solubility, encapsulation efficiency (EE), X-ray diffraction (X-RD), Differential Scanning Calorimeter (DSC) and drug-polymer interaction by Fourier transforms infrared spectroscopy.</p><p><strong>Results: </strong>The amorphous nature of the drug's incorporation in solid dispersion was confirmed by X-RD analysis. Prepared solid dispersion showed higher solubility, 11.51 mg, than pure OLZ (0.983 mg ml<sup>-1</sup>), while the range of EE was found to be between 64 to 90 %.</p><p><strong>Conclusions: </strong>The solubility and dissolution rate of the OLZ can effectively increase by spray-dried solid dispersion. Plackett-Burman screening design plays a vital role in understanding the effect of independent variables on EE and solubility.</p>","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"11 4","pages":"615-627"},"PeriodicalIF":2.5,"publicationDate":"2023-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626510/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71476976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Supremacy of nanoparticles in the therapy of chronic myelogenous leukemia. 纳米颗粒在治疗慢性粒细胞白血病中的优势。
IF 2.5 Q2 CHEMISTRY, MEDICINAL Pub Date : 2023-09-26 eCollection Date: 2023-01-01 DOI: 10.5599/admet.2013
Gopalarethinam Janani, Agnishwar Girigoswami, Koyeli Girigoswami

Background and purpose: The reciprocal translocation of the ABL gene from chromosome 9 to chromosome 22 near the BCR gene gives rise to chronic myelogenous leukemia (CML). The translocation results in forming the Philadelphia chromosome (BCR-ABL) tyrosine kinase. CML results in an increase in the number of white blood cells and alteration in tyrosine kinase expression. CML prognosis includes three stages, namely chronic, accelerated, and blast. The diagnosis method involves a CT scan, biopsy, and complete blood count. However, due to certain disadvantages, early diagnosis of CML is not possible by traditional methods. Nanotechnology offers many advantages in diagnosing and treating cancer.

Experimental approach: We searched PubMed, Scopus and Google Scholar using the keywords Philadelphia chromosome, bionanotechnology, tyrosine kinase pathway, half-life, passive targeting, and organic and inorganic nanoparticles. The relevant papers and the classical papers in this field were selected to write about in this review.

Key results: The sensitivity and specificity of an assay can be improved by nanoparticles. Utilizing this property, peptides, antibodies, aptamers, etc., in the form of nanoparticles, can be used to detect cancer at a much earlier stage. The half-life of the drug is also increased by nanoformulation. The nanoparticle-coated drugs can easily escape from the immune system.

Conclusion: Depending on their type, nanoparticles can be categorized into organic, inorganic and hybrid. Each type has its advantages. Organic nanoparticles have good biocompatibility, inorganic nanoparticles increase the half-life of the drugs. In this review, we highlight the nanoparticles involved in treating CML.

背景和目的:ABL基因从BCR基因附近的9号染色体到22号染色体的相互易位引起慢性粒细胞白血病(CML)。易位导致形成费城染色体(BCR-ABL)酪氨酸激酶。CML导致白细胞数量增加和酪氨酸激酶表达改变。慢性粒细胞白血病的预后包括三个阶段,即慢性期、加速期和爆发期。诊断方法包括CT扫描、活检和全血细胞计数。然而,由于某些缺点,传统方法不可能对慢性粒细胞白血病进行早期诊断。纳米技术在诊断和治疗癌症方面具有许多优势。实验方法:我们使用关键词Philadelphia染色体、生物技术、酪氨酸激酶途径、半衰期、被动靶向以及有机和无机纳米颗粒搜索PubMed、Scopus和Google Scholar。本综述选取了该领域的相关论文和经典论文进行写作。关键结果:纳米颗粒可以提高检测的灵敏度和特异性。利用这一特性,纳米颗粒形式的肽、抗体、适体等可以用于早期检测癌症。纳米制剂也增加了药物的半衰期。纳米颗粒包裹的药物可以很容易地从免疫系统中逃脱。结论:纳米颗粒根据其类型可分为有机、无机和杂化。每种类型都有其优点。有机纳米粒子具有良好的生物相容性,无机纳米粒子增加了药物的半衰期。在这篇综述中,我们重点介绍了参与治疗慢性粒细胞白血病的纳米颗粒。
{"title":"Supremacy of nanoparticles in the therapy of chronic myelogenous leukemia.","authors":"Gopalarethinam Janani, Agnishwar Girigoswami, Koyeli Girigoswami","doi":"10.5599/admet.2013","DOIUrl":"10.5599/admet.2013","url":null,"abstract":"<p><strong>Background and purpose: </strong>The reciprocal translocation of the ABL gene from chromosome 9 to chromosome 22 near the BCR gene gives rise to chronic myelogenous leukemia (CML). The translocation results in forming the Philadelphia chromosome (BCR-ABL) tyrosine kinase. CML results in an increase in the number of white blood cells and alteration in tyrosine kinase expression. CML prognosis includes three stages, namely chronic, accelerated, and blast. The diagnosis method involves a CT scan, biopsy, and complete blood count. However, due to certain disadvantages, early diagnosis of CML is not possible by traditional methods. Nanotechnology offers many advantages in diagnosing and treating cancer.</p><p><strong>Experimental approach: </strong>We searched PubMed, Scopus and Google Scholar using the keywords Philadelphia chromosome, bionanotechnology, tyrosine kinase pathway, half-life, passive targeting, and organic and inorganic nanoparticles. The relevant papers and the classical papers in this field were selected to write about in this review.</p><p><strong>Key results: </strong>The sensitivity and specificity of an assay can be improved by nanoparticles. Utilizing this property, peptides, antibodies, aptamers, etc., in the form of nanoparticles, can be used to detect cancer at a much earlier stage. The half-life of the drug is also increased by nanoformulation. The nanoparticle-coated drugs can easily escape from the immune system.</p><p><strong>Conclusion: </strong>Depending on their type, nanoparticles can be categorized into organic, inorganic and hybrid. Each type has its advantages. Organic nanoparticles have good biocompatibility, inorganic nanoparticles increase the half-life of the drugs. In this review, we highlight the nanoparticles involved in treating CML.</p>","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"11 4","pages":"499-511"},"PeriodicalIF":2.5,"publicationDate":"2023-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626512/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71476981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Eco-friendly synthesis of chitosan and its medical application: from chitin extraction to nanoparticle preparation. 壳聚糖的环保合成及其医学应用:从甲壳素提取到纳米粒子制备。
IF 2.5 Q2 CHEMISTRY, MEDICINAL Pub Date : 2023-09-23 eCollection Date: 2023-01-01 DOI: 10.5599/admet.1999
Riyona Desvy Pratiwi, Sjaikhurrizal El Muttaqien, Nunik Gustini, Najla Salsabilla Difa, Gita Syahputra, A'liyatur Rosyidah

Background and purpose: Chitosan, a chitin deacetylation product, has been applied in nanoparticle or nano-chitosan for medical applications. However, the chitin extraction from crustacean shells and other natural resources, chitin deacetylation, and crosslinking of the chitosan forming the nano-chitosan mostly involve hazardous chemical and physical processes. The risks of these processes to human health and the environment attract the attention of scientists to develop safer and greener techniques. This review aims to describe the progress of harmless chitosan synthesis.

Experimental approach: All strongly related publications to each section, which were found on scientific search engines (Google Scholar, Scopus, and Pubmed), were studied, selected, and then used as references in writing this review. No limitation for the publication year was applied. The publications were searched from April 2022 - June 2023.

Key results: Nano-chitosan could be synthesized in harmless techniques, including the preparation of the chitosan raw materials and crosslinking the chitosan polymer. Enzymatic processes in shell deproteination in the chitin extraction and deacetylation are preferable to reduce the negative effects of conventional chemical-physical processes. Mild alkalines and deep eutectic solvents also provide similar benefits. In the nano-chitosan synthesis, naturally derived compounds (carrageenan, genipin, and valinin) show potency as safer crosslinkers, besides tripolyphosphate, the most common safe crosslinker.

Conclusion: A list of eco-friendly and safer processes in the synthesis of nano-chitosan has been reported in recent years. These findings are suggested for the nano-chitosan synthesis on an industrial scale in the near future.

背景和目的:壳聚糖是一种甲壳素脱乙酰产物,已被应用于纳米或纳米壳聚糖的医疗应用。然而,从甲壳类动物壳和其他自然资源中提取甲壳质、甲壳质脱乙酰化和交联形成纳米壳聚糖大多涉及危险的化学和物理过程。这些过程对人类健康和环境的风险吸引了科学家的注意,以开发更安全、更环保的技术。本文综述了无害壳聚糖的合成进展。实验方法:研究、选择科学搜索引擎(Google Scholar、Scopus和Pubmed)上与每个章节有强烈关联的所有出版物,然后将其用作撰写本综述的参考文献。出版年份不受限制。检索时间为2022年4月至2023年6月。关键结果:纳米壳聚糖可以通过无害技术合成,包括壳聚糖原料的制备和壳聚糖聚合物的交联。壳聚糖提取和脱乙酰过程中的酶脱蛋白过程是优选的,以减少传统化学物理过程的负面影响。弱碱和深共晶溶剂也提供了类似的好处。在纳米壳聚糖的合成中,除了最常见的安全交联剂三聚磷酸盐外,天然衍生的化合物(卡拉胶、金雀花素和缬氨酸)也显示出作为更安全交联剂的潜力。结论:近年来报道了一系列环保、安全的纳米壳聚糖合成工艺。这些发现为不久的将来在工业规模上合成纳米壳聚糖提供了建议。
{"title":"Eco-friendly synthesis of chitosan and its medical application: from chitin extraction to nanoparticle preparation.","authors":"Riyona Desvy Pratiwi, Sjaikhurrizal El Muttaqien, Nunik Gustini, Najla Salsabilla Difa, Gita Syahputra, A'liyatur Rosyidah","doi":"10.5599/admet.1999","DOIUrl":"10.5599/admet.1999","url":null,"abstract":"<p><strong>Background and purpose: </strong>Chitosan, a chitin deacetylation product, has been applied in nanoparticle or nano-chitosan for medical applications. However, the chitin extraction from crustacean shells and other natural resources, chitin deacetylation, and crosslinking of the chitosan forming the nano-chitosan mostly involve hazardous chemical and physical processes. The risks of these processes to human health and the environment attract the attention of scientists to develop safer and greener techniques. This review aims to describe the progress of harmless chitosan synthesis.</p><p><strong>Experimental approach: </strong>All strongly related publications to each section, which were found on scientific search engines (Google Scholar, Scopus, and Pubmed), were studied, selected, and then used as references in writing this review. No limitation for the publication year was applied. The publications were searched from April 2022 - June 2023.</p><p><strong>Key results: </strong>Nano-chitosan could be synthesized in harmless techniques, including the preparation of the chitosan raw materials and crosslinking the chitosan polymer. Enzymatic processes in shell deproteination in the chitin extraction and deacetylation are preferable to reduce the negative effects of conventional chemical-physical processes. Mild alkalines and deep eutectic solvents also provide similar benefits. In the nano-chitosan synthesis, naturally derived compounds (carrageenan, genipin, and valinin) show potency as safer crosslinkers, besides tripolyphosphate, the most common safe crosslinker.</p><p><strong>Conclusion: </strong>A list of eco-friendly and safer processes in the synthesis of nano-chitosan has been reported in recent years. These findings are suggested for the nano-chitosan synthesis on an industrial scale in the near future.</p>","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"11 4","pages":"435-455"},"PeriodicalIF":2.5,"publicationDate":"2023-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626508/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71476977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The interactions of model cationic drug with newly synthesized starch derivatives. 模型阳离子药物与新合成的淀粉衍生物的相互作用。
IF 3.4 Q2 CHEMISTRY, MEDICINAL Pub Date : 2023-09-20 eCollection Date: 2023-01-01 DOI: 10.5599/admet.1950
Justyna Kobryń, Tomasz Zięba, Magdalena Rzepczyńska, Witold Musiał

Background and purpose: The aim of the work was to compare the interactions of three newly synthesized non-toxic starch derivatives, with varied anionic and non-ionic functional groups with methylene blue (MB) as a model cationic drug, and selection of starch derivative with highest affinity to the MB.

Experimental approach: The native potato starch (SN), modified via acetylation (SM1), esterification and crosslinking (SM2) and crosslinking (SM3), was evaluated in MB adsorption studies and assessed by FTIR, PXRD, and DSC.

Key results: The adsorption of MB on SM2 and SM3 matched the BET isotherm model, which confirmed physisorption on the low-porous surface. In the case of SM1, adsorption took place via electrostatic attraction between the heterogeneous adsorbent surface and the adsorbate, as demonstrated by the Freundlich plot. The FTIR confirmed vibrations assigned to N=C stretching bonds at 1600 cm-1 in the case of MB adsorbed on the SN and SM2. The most intense PXRD peaks belonged to SN and the least to SM2. In the DSC study, the thermal stability via ΔT was assessed, with SM2 of lowest ΔT value (179.8 °C).

Conclusion: SM2 presented the best adsorption capacity, followed by SM3 and the weakest SM1. The interactions were confirmed in the adsorption studies and may reflect applications of the modified starches as drug carriers. In the FTIR study, a probable interaction between the OH- groups of SM2 and N+ of MB was revealed. The most amorphous structure was shown for SM2, which was correlated with the lowest thermal stability provided by the DSC study.

背景和目的:本工作的目的是比较三种新合成的具有不同阴离子和非离子官能团的无毒淀粉衍生物与亚甲基蓝(MB)作为模型阳离子药物的相互作用,并选择对MB亲和力最高的淀粉衍生物,在MB吸附研究中评估了酯化和交联(SM2)以及交联(SM3),并通过FTIR、PXRD和DSC进行了评估。关键结果:MB在SM2和SM3上的吸附符合BET等温线模型,证实了在低孔表面上的物理吸附。在SM1的情况下,吸附通过非均相吸附剂表面和吸附质之间的静电吸引发生,如Freundlich图所示。FTIR证实了在MB吸附在SN和SM2上的情况下,在1600cm-1处归属于N=C伸缩键的振动。最强的PXRD峰属于SN,最小的属于SM2。在DSC研究中,通过ΔT评估了热稳定性,其中SM2的ΔT值最低(179.8°C)。结论:SM2的吸附能力最好,其次是SM3,SM1最弱。吸附研究证实了这种相互作用,可能反映了改性淀粉作为药物载体的应用。在FTIR研究中,揭示了SM2的OH-基团与MB的N+之间可能的相互作用。SM2显示出最无定形的结构,这与DSC研究提供的最低热稳定性有关。
{"title":"The interactions of model cationic drug with newly synthesized starch derivatives.","authors":"Justyna Kobryń, Tomasz Zięba, Magdalena Rzepczyńska, Witold Musiał","doi":"10.5599/admet.1950","DOIUrl":"10.5599/admet.1950","url":null,"abstract":"<p><strong>Background and purpose: </strong>The aim of the work was to compare the interactions of three newly synthesized non-toxic starch derivatives, with varied anionic and non-ionic functional groups with methylene blue (MB) as a model cationic drug, and selection of starch derivative with highest affinity to the MB.</p><p><strong>Experimental approach: </strong>The native potato starch (SN), modified <i>via</i> acetylation (SM1), esterification and crosslinking (SM2) and crosslinking (SM3), was evaluated in MB adsorption studies and assessed by FTIR, PXRD, and DSC.</p><p><strong>Key results: </strong>The adsorption of MB on SM2 and SM3 matched the BET isotherm model, which confirmed physisorption on the low-porous surface. In the case of SM1, adsorption took place <i>via</i> electrostatic attraction between the heterogeneous adsorbent surface and the adsorbate, as demonstrated by the Freundlich plot. The FTIR confirmed vibrations assigned to N=C stretching bonds at 1600 cm<sup>-1</sup> in the case of MB adsorbed on the SN and SM2. The most intense PXRD peaks belonged to SN and the least to SM2. In the DSC study, the thermal stability <i>via</i> Δ<i>T</i> was assessed, with SM2 of lowest Δ<i>T</i> value (179.8 °C).</p><p><strong>Conclusion: </strong>SM2 presented the best adsorption capacity, followed by SM3 and the weakest SM1. The interactions were confirmed in the adsorption studies and may reflect applications of the modified starches as drug carriers. In the FTIR study, a probable interaction between the OH<sup>-</sup> groups of SM2 and N<sup>+</sup> of MB was revealed. The most amorphous structure was shown for SM2, which was correlated with the lowest thermal stability provided by the DSC study.</p>","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"11 3","pages":"387-407"},"PeriodicalIF":3.4,"publicationDate":"2023-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567071/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41187995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
ADMET and DMPK
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1